IMU (ASX) Why IMU is a multi multi bagger

Originally posted by Footmax ↑

This is interesting - another immunology based cancer treatment.

New skin cancer vaccine could turn the tide on melanoma (thenewdaily.com.au)
Skin cancer vaccine could turn the tide on melanoma

Anew mRNA vaccine has been found to greatly reduce the rate of death after amelanoma is cut out. Photo:Getty
Most people only became familiar with mRNA vaccines during the Covid-19pandemic, but new research has found that a mRNA skin cancer vaccine cansignificantly reduce death in people who have suffered from melanoma.
The research, being presented at the 2024 American Society of ClinicalOncology’s annual meeting by Australian of the Year Professor Georgina Long,found that the developed vaccine, when given in combination with animmunotherapy drug, resulted in an increased survival rate for people who hadsuffered from melanoma.
Dr Kyle Holden, Moderna’s senior vice president and head of development,said the findings highlighted the benefit of the combined treatment for peoplewith high-risk melanomas that had been removed.
“These findings reinforce our commitment to advancing this innovativetreatment,” he said in a statement.
“We are dedicated to harnessing mRNA technology to potentially transformcancer therapy and improve patient outcomes.”
Moderna and Merck, the two pharmaceutical companies who funded thevaccine, will launch phase-three studies for people “with high-risk melanomaand non-small cell lung cancer”.
Melanoma is a highly aggressive form of skin cancer, with more than15,000 Australians diagnosed each year, and is considered one of the worstbecause it spreads through the body.
mRNA vaccines
Messenger RNA may have been new to many people in recent years,researchers have been studying and working with the vaccines for the flu, zikavirus and rabies for decades.
They work by creating a protein, or part of the virus, when injected,resulting in the body’s immune system learning how to create a response to it,compared to traditional vaccines that contain an inactive microbe of the viruswhich then creates the immune response.
In the simplest terms, mRNA serves as an instruction manual for thebody, while traditional vaccines stimulate the immune response with a deadversion of the virus.
The research found that the two-and-a-half-year survival rate of themRNA vaccine was 74.8 per cent, compared to 55.6 per cent for just theimmunotherapy drug, representing a substantial increase.
Australia’s cancer
Australia has one of the highest melanoma rates in the world, so itshouldn’t be a surprise that Long, who is the co-director of the MelanomaInstitute Australia, is presenting the findings.
Two-thirds of Australians will experience melanoma in their lifetime androughly 2000 die each year from skin cancer.

Two-thirds ofAustralians will experience a form of skin cancer in their lifetime. Photo: Getty
It is expected that 16,800 Australians, or one every 30 minutes, will bediagnosed with melanoma in 2024.
Australia’s current national cancer plan aims to maximise cancer prevention and early detection, while informing people on the risks of not wearing sunscreen.
The vaccine research follows another promising treatment being discovered by Australian researchers earlier in this year.

Expand

They don't seem to quote percentages???
Suspect! Should one have good results most mention actual figures. Imo.
They'll have to heal completely at near 100% to compete with IMU!

No.	Vol.	Price($)
7	299925	5.6¢

No.

Vol.

Price($)

299925

5.6¢

Price($)	Vol.	No.
5.7¢	463968	17

Price($)

Vol.

No.

5.7¢

463968

No.	Vol.	Price($)
40	4426542	0.055
22	3240675	0.054
23	4247974	0.053
18	1461472	0.052
17	1738330	0.051

No.

Vol.

Price($)

4426542

0.055

3240675

0.054

4247974

0.053

1461472

0.052

1738330

0.051

Price($)	Vol.	No.
0.056	291975	19
0.057	478440	15
0.058	868369	5
0.059	722079	6
0.060	832697	9

Price($)

Vol.

No.

0.056

291975

0.057

478440

0.058

868369

0.059

722079

0.060

832697

(20min delay)
Last 5.6¢		Change -0.004(6.67%)		Mkt cap ! $411.5M

Open	High	Low	Value	Volume
5.9¢	5.9¢	5.5¢	$1.146M	20.10M

Why IMU is a multi multi bagger, page-23983

Opyl forms JV with UK and US consortium to bring products to the world

Hexima shares rise 66% on proposed acquisition of AI player Real Thing Entertainment

NYSE-listed Alcoa Corp joins ASX through key JV acquisition

Acquisitions roundup: European Lithium, Diatreme Resources and SRJ Technologies

Drilling at Lady Ilse suggests gold-copper porphyry, grows footprint for Magmatic

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Why IMU is a multi multi bagger, page-23983

Top Stories

Opyl forms JV with UK and US consortium to bring products to the world

Hexima shares rise 66% on proposed acquisition of AI player Real Thing Entertainment

NYSE-listed Alcoa Corp joins ASX through key JV acquisition

Acquisitions roundup: European Lithium, Diatreme Resources and SRJ Technologies

Drilling at Lady Ilse suggests gold-copper porphyry, grows footprint for Magmatic

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News